2026-08-29T14:07:46Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/267612025-12-18T12:56:53Zcom_20.500.12105_19604com_20.500.12105_2051col_20.500.12105_19605

00925njm 22002777a 4500 dc Genius, Patricia author Calle, M Luz author Rodríguez-Fernández, Blanca author Minguillon, Carolina author Cacciaglia, Raffaele author Garrido-Martin, Diego author Esteller, Manel author Navarro, Arcadi author Gispert, Juan Domingo author Vilor-Tejedor, Natalia author 2025-02 Traditional multivariate methods for neuroimaging studies overlook the interdependent relationship between brain features. This study addresses this gap by analyzing relative brain volumetric patterns to capture how Alzheimer's disease (AD) and genetics influence brain structure along the disease continuum. This study analyzed data from participants across the AD continuum from the Alzheimer's and Families (ALFA) and Alzheimer's Disease Neuroimaging Initiative (ADNI) studies. Compositional data analysis (CoDA) was exploited to examine relative brain volumetric variations that (1) were linked to different AD stages compared to cognitively unimpaired amyloid-β-negative (CU A-) individuals and (2) varied by AD genetic risk. Disease stage-specific compositional brain scores were identified, differentiating CU A- individuals from those in more advanced stages. Genetic risk-stratified models revealed a broader genetic landscape affecting brain morphology in AD, beyond the well-known apolipoprotein E ε4 allele. CoDA emerges as an alternative multivariate framework to deepen understanding of AD-related structural changes and support targeted interventions for those at higher genetic risk. Alzheimers Dement. 2025 Feb;21(2):e14490. Alzheimers & Dementia 39868465 https://hdl.handle.net/20.500.12105/26761 Alzheimer's disease genetic predisposition brain imaging genetics compositional brain score compositional data analysis multi phenotype analysis neurodegeneration polygenic risk scoring Compositional brain scores capture Alzheimer's disease-specific structural brain patterns along the disease continuum.